WHEN TOP EXECUTIVES WANT to discuss business in Mumbai, they usually head to either the Taj Chambers or the Oberoi Belvedere. Now there’s another option. The Club at the Four Seasons Hotel Mumbai is carving out its place as a mid-city business meeting address. Since its opening in 2009, The Club has signed up 350 members, says Andrew Harrison, the hotel’s general manager. The interiors of The Club, on the 33rd floor, were done by Florida-based Bilkey Llinas Design. It boasts four private meeting rooms, a lounge area, bar, library, wine cellar, and the city’s only in-house cigar lounge. The Chambers and the Belvedere charge an “initiation fee” of Rs 10 lakh and Rs 15 lakh, respectively, besides an annual fee of Rs 75,000 and Rs 50,000. The Club’s fees, at Rs 1.2 lakh a year or Rs 6 lakh for 10 years, broadens the field, attracting executives who aspire to a corporate club membership but find the fees daunting.
Top Stories
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.